Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy.
Fiche publication
Date publication
juin 2011
Journal
European journal of obstetrics, gynecology, and reproductive biology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CHALOPIN Jean-Marc, Pr PIVOT Xavier, Dr ROYER Bernard, Pr HEYD Bruno
Tous les auteurs :
Pili-Floury S, Royer B, Bartholin F, Crumiere N, Combe M, Chalopin JM, Pivot X, Heyd B, Chauffert B, Samain E
Lien Pubmed
Résumé
Intra-operative cisplatin-based intra-peritoneal chemotherapy (IPC) may alter renal function in patients with advanced ovarian cancer. The aim of this study was to describe postoperative alteration of renal function after cisplatin-based IPC and to identify risk factors for moderate to severe acute renal failure.
Mots clés
Acute Kidney Injury, chemically induced, Adult, Aged, Antineoplastic Agents, administration & dosage, Cisplatin, administration & dosage, Epinephrine, administration & dosage, Female, Humans, Infusions, Parenteral, Kidney, drug effects, Middle Aged, Ovarian Neoplasms, drug therapy, Prospective Studies, Vasoconstrictor Agents, administration & dosage
Référence
Eur. J. Obstet. Gynecol. Reprod. Biol.. 2011 Jun;156(2):199-203